Αποτελέσματα Αναζήτησης
21 Μαΐ 2013 · (BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced its intention to split off its remaining interest in Zoetis Inc. (NYSE: ZTS), through an exchange offer. Zoetis, formerly Pfizer’s animal health business, completed its initial public offering (IPO) in February 2013.
4 Φεβ 2013 · Pfizer completed the spin-out of animal health unit Zoetis last Friday via an initial public offering (IPO) that appears to have been well-received by the market. Zoetis debuted on the New York Stock Exchange under the ZTS ticker symbol and closed the day up 20 per cent from its start price at $31.01 – a little down from a high of $31.50 ...
22 Μαΐ 2013 · Pfizer Inc. (NYSE: PFE) today announced its intention to split off its remaining interest in Zoetis Inc. (NYSE: ZTS), through an exchange offer. Zoetis, formerly Pfizer's animal health business, completed its initial public offering (IPO) in February 2013.
31 Ιαν 2013 · Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines for livestock and companion animals.
20 Ιουν 2013 · Pfizer Inc. (NYSE:PFE) announced the split off of 80.2% stake of Zoetis Inc. (NYSE:ZTS) to shareholders of Pfizer Inc. for $13.2 billion on May 22, 2013. Shareholders of Pfizer will receive 0.9898 shares of Zoetis common stock for each share of Pfizer common stock.
22 Μαΐ 2013 · Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7...
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in
